AllianceBernstein’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.6M Buy
1,255,203
+7,823
+0.6% +$284K 0.01% 623
2025
Q1
$45.2M Sell
1,247,380
-380,552
-23% -$13.8M 0.02% 613
2024
Q4
$68.5M Buy
1,627,932
+81,667
+5% +$3.44M 0.02% 511
2024
Q3
$85.9M Buy
1,546,265
+18,390
+1% +$1.02M 0.03% 467
2024
Q2
$62.8M Buy
1,527,875
+45,404
+3% +$1.87M 0.02% 540
2024
Q1
$69.2M Sell
1,482,471
-96,132
-6% -$4.49M 0.02% 513
2023
Q4
$75.5M Buy
1,578,603
+46,098
+3% +$2.2M 0.03% 482
2023
Q3
$54.6M Buy
1,532,505
+18,738
+1% +$668K 0.02% 529
2023
Q2
$69.8M Buy
1,513,767
+84,353
+6% +$3.89M 0.03% 485
2023
Q1
$57.3M Sell
1,429,414
-112,263
-7% -$4.5M 0.02% 527
2022
Q4
$71.4M Buy
1,541,677
+228,144
+17% +$10.6M 0.03% 475
2022
Q3
$54.4M Buy
1,313,533
+79,409
+6% +$3.29M 0.03% 519
2022
Q2
$73.6M Sell
1,234,124
-139,305
-10% -$8.31M 0.03% 450
2022
Q1
$99.7M Buy
1,373,429
+65,273
+5% +$4.74M 0.04% 406
2021
Q4
$110M Buy
1,308,156
+152,002
+13% +$12.8M 0.04% 419
2021
Q3
$104M Sell
1,156,154
-25,693
-2% -$2.32M 0.04% 411
2021
Q2
$113M Buy
1,181,847
+34,414
+3% +$3.28M 0.05% 394
2021
Q1
$131M Sell
1,147,433
-40,136
-3% -$4.57M 0.06% 329
2020
Q4
$164M Sell
1,187,569
-193,983
-14% -$26.9M 0.08% 237
2020
Q3
$114M Sell
1,381,552
-34,144
-2% -$2.81M 0.06% 283
2020
Q2
$111M Buy
1,415,696
+2,655
+0.2% +$208K 0.07% 277
2020
Q1
$62.8M Sell
1,413,041
-134,352
-9% -$5.97M 0.05% 380
2019
Q4
$66.1M Buy
1,547,393
+211,635
+16% +$9.04M 0.04% 469
2019
Q3
$57.1M Buy
1,335,758
+170,136
+15% +$7.28M 0.04% 486
2019
Q2
$74M Buy
1,165,622
+35,390
+3% +$2.25M 0.05% 411
2019
Q1
$78.4M Buy
1,130,232
+122,009
+12% +$8.46M 0.05% 378
2018
Q4
$43.8M Buy
1,008,223
+15,866
+2% +$690K 0.03% 512
2018
Q3
$75.8M Buy
992,357
+50,489
+5% +$3.85M 0.05% 388
2018
Q2
$72.4M Buy
941,868
+44,556
+5% +$3.43M 0.05% 393
2018
Q1
$45.8M Buy
897,312
+196,906
+28% +$10M 0.03% 509
2017
Q4
$32.5M Buy
700,406
+56,106
+9% +$2.6M 0.02% 621
2017
Q3
$34.3M Sell
644,300
-44,906
-7% -$2.39M 0.03% 597
2017
Q2
$42.8M Buy
689,206
+114,897
+20% +$7.14M 0.03% 519
2017
Q1
$38.9M Sell
574,309
-93,949
-14% -$6.37M 0.03% 529
2016
Q4
$47M Buy
668,258
+53,215
+9% +$3.74M 0.04% 467
2016
Q3
$43.6M Buy
615,043
+236,848
+63% +$16.8M 0.04% 483
2016
Q2
$18.5M Sell
378,195
-18,344
-5% -$897K 0.02% 717
2016
Q1
$25.1M Buy
396,539
+10,438
+3% +$661K 0.02% 614
2015
Q4
$43.3M Sell
386,101
-17,616
-4% -$1.98M 0.04% 479
2015
Q3
$38.9M Buy
403,717
+46,627
+13% +$4.49M 0.03% 489
2015
Q2
$36.6M Buy
357,090
+52,905
+17% +$5.42M 0.03% 547
2015
Q1
$18.9M Sell
304,185
-7,888
-3% -$490K 0.02% 744
2014
Q4
$13.7M Buy
312,073
+3,065
+1% +$134K 0.01% 807
2014
Q3
$17.5M Buy
309,008
+4,039
+1% +$229K 0.01% 720
2014
Q2
$13.7M Buy
304,969
+57,872
+23% +$2.6M 0.01% 796
2014
Q1
$12.1M Buy
+247,097
New +$12.1M 0.01% 805